These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21114899)

  • 21. Plasma cell maturity as a predictor of prognosis in multiple myeloma.
    Iriyama N; Miura K; Hatta Y; Uchino Y; Kurita D; Takahashi H; Sakagami H; Sakagami M; Kobayashi Y; Nakagawa M; Ohtake S; Iizuka Y; Takei M
    Med Oncol; 2016 Aug; 33(8):87. PubMed ID: 27383407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunophenotype and DNA content of myeloma cells in primary plasma cell leukemia.
    Shimazaki C; Gotoh H; Ashihara E; Oku N; Inaba T; Murakami S; Itoh K; Ura Y; Nakagawa M; Fujita N
    Am J Hematol; 1992 Mar; 39(3):159-62. PubMed ID: 1546712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma.
    Weinhold N; Kirn D; Seckinger A; Hielscher T; Granzow M; Bertsch U; Egerer G; Salwender H; Blau IW; Weisel K; Hillengass J; Raab MS; Hose D; Goldschmidt H; Jauch A
    Haematologica; 2016 Mar; 101(3):e116-9. PubMed ID: 26611471
    [No Abstract]   [Full Text] [Related]  

  • 24. [DNA content and cell cycle analysis of myeloma cells in patients with multiple myeloma].
    Sun WL; Wu YJ; Wang X; Li H; Zhuang JL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):824-8. PubMed ID: 18718069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma].
    Pasqualetti P; Colantonio D; Casale R
    Minerva Med; 1990 Mar; 81(3):129-33. PubMed ID: 2320280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma: clinical implications.
    Bunn PA; Krasnow S; Makuch RW; Schlam ML; Schechter GP
    Blood; 1982 Mar; 59(3):528-35. PubMed ID: 6800416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
    Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
    Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Flow cytometric analysis of the DNA content in resected thymomas].
    Kushibe K; Iioka S; Nezu K; Sawahata A; Tojo H; Kitamura S
    Kyobu Geka; 1993 Jan; 46(1):79-83. PubMed ID: 8418365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma.
    Gonsalves WI; Timm MM; Rajkumar SV; Morice WG; Dispenzieri A; Buadi FK; Lacy MQ; Dingli D; Leung N; Kapoor P; Kyle RA; Gertz MA; Kumar SK
    Leuk Res; 2016 May; 44():32-9. PubMed ID: 26994849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Flow cytometric DNA analysis in colorectal cancer].
    Ando Y; Tsuchiya A; Sekikawa K; Ishii Y; Yoshida T; Kimijima I; Abe R
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1571-5. PubMed ID: 2586468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic abnormalities and patterns of antigenic expression in multiple myeloma.
    Mateo G; Castellanos M; Rasillo A; Gutiérrez NC; Montalbán MA; Martín ML; Hernández JM; López-Berges MC; Montejano L; Bladé J; Mateos MV; Sureda A; de la Rubia J; Díaz-Mediavilla J; Pandiella A; Lahuerta JJ; Orfao A; San Miguel JF
    Clin Cancer Res; 2005 May; 11(10):3661-7. PubMed ID: 15897562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics.
    Vagnoni D; Travaglini F; Pezzoni V; Ruggieri M; Bigazzi C; Dalsass A; Mestichelli F; Troiani E; Falcioni S; Mazzotta S; Natale A; Angelini M; Ferretti S; Angelini S; Galieni P
    Br J Haematol; 2015 Aug; 170(4):523-31. PubMed ID: 26010293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiparameter flow cytometry evaluation of plasma cell DNA content and proliferation in 595 transplant-eligible patients with myeloma included in the Spanish GEM2000 and GEM2005<65y trials.
    Paiva B; Vídriales MB; Montalbán MÁ; Pérez JJ; Gutiérrez NC; Rosiñol L; Martínez-López J; Mateos MV; Cordón L; Oriol A; Terol MJ; Echeveste MA; De Paz R; De Arriba F; Palomera L; de la Rubia J; Díaz-Mediavilla J; Sureda A; Gorosquieta A; Alegre A; Martin A; Lahuerta JJ; Bladé J; Orfao A; San Miguel JF
    Am J Pathol; 2012 Nov; 181(5):1870-8. PubMed ID: 22974582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ploidy and proliferative characteristics in monoclonal gammopathies.
    Latreille J; Barlogie B; Johnston D; Drewinko B; Alexanian R
    Blood; 1982 Jan; 59(1):43-51. PubMed ID: 6172171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The importance of blast cell DNA content for prognosis of childhood acute lymphoblastic leukemia.
    Starý J; Hrodek O; Hausner P; Petráková A; Goetz P; Kreuger A
    Neoplasma; 1990; 37(3):293-9. PubMed ID: 2370916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic significance of DNA content measured by flow cytometry in supraglottic laryngeal carcinoma].
    Morales Angulo C; Fernández Fernández F; Val Bernal F; Buelta L; García-Castrillo L; Rama Quintela J
    Acta Otorrinolaringol Esp; 1997; 48(6):483-6. PubMed ID: 9471196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments.
    Kumar S; Rajkumar SV; Greipp PR; Witzig TE
    Am J Hematol; 2004 Sep; 77(1):7-11. PubMed ID: 15307099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marrow cytometry and prognosis in myeloma.
    Barlogie B; Alexanian R; Gehan EA; Smallwood L; Smith T; Drewinko B
    J Clin Invest; 1983 Sep; 72(3):853-61. PubMed ID: 6193144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.